Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia

Research output: Contribution to journalArticle

Original languageEnglish
JournalLeukemia Research
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 2012

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this